PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection

Veterinary Research

Volumn 46, Issue 1, 2015, Pages

  Koinig, Hanna C ^a   Talker, Stephanie C ^a   Stadler, Maria ^a   Ladinig, Andrea ^a   Graage, Robert ^a,b   Ritzmann, Mathias ^a,c   Hennig Pauka, Isabel ^a   Gerner, Wilhelm ^a   Saalmüller, Armin ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; SUBUNIT VACCINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS VACCINE;

ANIMAL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; FLOW CYTOMETRY; HUMORAL IMMUNITY; IMMUNOLOGY; METABOLISM; PIG; POLYMERASE CHAIN REACTION; SWINE DISEASE; VACCINATION; VETERINARY; VIREMIA; VIROLOGY; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; FLOW CYTOMETRY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTERFERON-GAMMA; POLYMERASE CHAIN REACTION; SWINE; SWINE DISEASES; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, SUBUNIT; VIRAL LOAD; VIRAL VACCINES; VIREMIA;

EID: 84924029913     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/s13567-015-0157-4     Document Type: Article

References (41)

1. Tischer I, Gelderblom H, Vettermann W, Koch MA (1982) A very small porcine virus with circular single-stranded DNA. Nature 295:64-66
2. Segalés J, Kekarainen T, Cortey M (2013) The natural history of porcine circovirus type 2: From an inoffensive virus to a devastating swine disease? Vet Microbiol 165:13-20
3. Chae C (2005) A review of porcine circovirus 2-associated syndromes and diseases. Vet J 169:326-336
4. Segalés J (2012) Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res 164:10-19
5. Opriessnig T, Halbur PG (2012) Concurrent infections are important for expression of porcine circovirus associated disease. Virus Res 164:20-32
6. Opriessnig T, O'Neill K, Gerber PF, de Castro AMMG, Gimenéz-Lirola LG, Beach NM, Zhou L, Meng X, Wang C, Halbur PG (2013) A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Vaccine 31:487-494
7. Seo HW, Park SJ, Park C, Chae C (2014) Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs. Vaccine 32:2480-2486
8. Opriessnig T, Meng X, Halbur PG (2007) Porcine circovirus type 2-associated disease: Update on current terminology, clinical manifestations, pathogenesis, diagnosis and intervention strategies. J Vet Diagn Invest 19:591-615
9. Mahé D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F, Albina E, Jestin A (2000) Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. J Gen Virol 81:1815-1824
10. Blanchard P, Mahé D, Cariolet R, Keranflec'h A, Baudouard MA, Cordioli P, Albina E, Jestin A (2003) Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 21:4565-4575
11. Beach NM, Meng X (2012) Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 164:33-42
12. Velasova M, Alarcon P, Werling D, Nevel A, Wieland B (2013) Effectiveness of porcine circovirus type 2 vaccination in reducing the severity of postweaning multisystemic wasting syndrome. Vet J 197:842-847
13. Alarcon P, Rushton J, Nathues H, Wieland B (2013) Economic efficiency analysis of different strategies to control post-weaning multi-systemic wasting syndrome and porcine circovirus type 2 subclinical infection in 3-weekly batch system farms. Prev Vet Med 110:103-118
14. Puvanendiran S, Stone S, Yu W, Johnson CR, Abrahante J, Jimenez LG, Griggs T, Haley C, Wagner B, Murtaugh M (2011) Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV2 exposure and infection in swine finisher herds. Virus Res 157:92-98
15. Rodríguez-Arrioja GM, Segalés J, Calsamiglia M, Resendes AR, Balasch M, Plana-Durán J, Casal J, Domingo M (2002) Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome. Am J Vet Res 63:354-357
16. Sibila M, Calsamiglia M, Segalés J, Blanchard P, Badiella L, Le Dimna M, Jestin A, Domingo M (2004) Use of polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am J Vet Res 65:88-92
17. Trible BR, Ramirez A, Suddith A, Fuller A, Kerrigan M, Hesse R, Nietfeld J, Guo B, Thacker E, Rowland RRR (2012) Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition. Vaccine 30:4079-4085
18. Meerts P, Misinzo G, Lefebvre D, Nielsen J, Bøtner A, Kristensen CS, Nauwynck HJ (2006) Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2:6
19. Fort M, Olvera A, Sibila M, Segalés J, Mateu E (2007) Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Vet Microbiol 125:244-255
20. Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J (2010) Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection. Vet Immunol Immunopathol 137:226-234
21. Steiner E, Balmelli C, Gerber H, Summerfield A, McCullough K (2009) Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. BMC Vet Res 5:45
22. Fort M, Fernandes LT, Nofrarías M, Díaz I, Sibila M, Pujols J, Mateu E, Segalés J (2009) Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet Immunol Immunopathol 129:101-107
23. Saalmüller A, Reddehase MJ, Bühring HJ, Jonjic S, Koszinowski UH (1987) Simultaneous expression of CD4 and CD8 antigens by a substantial proportion of resting porcine T lymphocytes. Eur J Immunol 17:1297-1301
24. Chae C (2004) Postweaning multisystemic wasting syndrome: A review of aetiology, diagnosis and pathology. Vet J 168:41-49
25. Meng X (2013) Porcine circovirus type 2 (PCV2): Pathogenesis and interaction with the immune system. Annu Rev Anim Biosci 1:43-64
26. Kixmöller M, Ritzmann M, Eddicks M, Saalmüller A, Elbers K, Fachinger V (2008) Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 26:3443-3451
27. Fachinger V, Bischoff R, Jedidia SB, Saalmüller A, Elbers K (2008) The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 26:1488-1499
28. Seo HW, Han K, Park C, Chae C (2014) Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines. Vet J 200:65-70
29. Patterson AR, Johnson J, Ramamoorthy S, Meng X, Halbur PG, Opriessnig T (2008) Comparison of three enzyme-linked immunosorbent assays to detect porcine circovirus-2 (PCV-2)-specific antibodies after vaccination or inoculation of pigs with distinct PCV-1 or PCV-2 isolates. J Vet Diagn Invest 20:744-751
30. Patterson AR, Johnson JK, Ramamoorthy S, Hesse RA, Murtaugh MP, Puvanendiran S, Pogranichniy RM, Erickson GA, Carman S, Hause B, Meng X, Opriessnig T (2011) Interlaboratory comparison of porcine circovirus-2 indirect immunofluorescent antibody test and enzyme-linked immunosorbent assay results on experimentally infected pigs. J Vet Diagn Invest 23:206-212
31. Martelli P, Ardigò P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Luppi A, Guazzetti S, Caleffi A, Borghetti P (2013) Concurrent vaccination against PCV2 and PRRSV: Study on specific immunity and clinical protection in naturally infected pigs. Vet Microbiol 162:558-571
32. Saalmüller A, Werner T, Fachinger V (2002) T-helper cells from naive to committed. Vet Immunol Immunopathol 87:137-145
33. Reutner K, Leitner J, Müllebner A, Ladinig A, Essler SE, Duvigneau JC, Ritzmann M, Steinberger P, Saalmüller A, Gerner W (2013) CD27 expression discriminates porcine T helper cells with functionally distinct properties. Vet Res 44:18
34. Ferrari L, Borghetti P, De Angelis E, Martelli P (2014) Memory T cell proliferative responses and IFN-γ productivity sustain a long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease. Vet Res 45:44
35. Kekarainen T, McCullough K, Fort M, Fossum C, Segalés J, Allan GM (2010) Immune responses and vaccine-induced immunity against porcine circovirus type 2. Vet Immunol Immunopathol 136:185-193
36. Seo HW, Oh Y, Han K, Park C, Chae C (2012) Reduction of porcine circovirus type 2 (PCV2) viremia by a reformulated inactivated chimeric PCV1-2 vaccine-induced humoral and cellular immunity after experimental PCV2 challenge. BMC Vet Res 8:194
37. Fort M, Sibila M, Nofrarías M, Pérez-Martín E, Olvera A, Mateu E, Segalés J (2012) Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine. Vet Immunol Immunopathol 150:128-132
38. Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P (2011) One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 149:339-351
39. Fort M, Sibila M, Pérez-Martín E, Nofrarías M, Mateu E, Segalés J (2009) One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 27:4031-4037
40. Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8:247-258
41. H1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843-850